AMY CUTCHEN: Open Payments
NPI 1124584479 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$567 in 25 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $49 · 2025 $567
Food & beverage: $567
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $105 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $80 |
| Lundbeck LLC | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $54 |
| Collegium Pharmaceutical, Inc. | 3 | $53 |
| MDD US Operations, LLC | 1 | $43 |
| Sage Therapeutics, LLC | 1 | $36 |
| ABBVIE INC. | 2 | $34 |
| Almatica Pharma LLC | 2 | $33 |
| Neurocrine BioSciences, Inc. | 1 | $28 |
Products named: AUSTEDO XR, TRINTELLIX, REXULTI, FANAPT, Jornay PM, Qelbree, ZURZUVAE, VRAYLAR.
Industry payments across FL — which companies pay providers there.
